Sale

Retinitis Pigmentosa Treatment Market

Global Retinitis Pigmentosa Treatment Market Size, Forecast: By Type: Autosomal Recessive RP, Autosomal Dominant RP, X-Linked RP; By Treatment: Drug, Device, Surgery, Others; By Distribution Channel: Hospital Retailer, Retail Retailer, Online; By End Use: Hospitals, Others; Regional Analysis; Competitive Landscape; 2024-2032

Global Retinitis Pigmentosa Treatment Market Outlook

The global retinitis pigmentosa treatment market is being driven by the growth of the retinal disorder treatment market. The global retinal disorder treatment market is expected to grow at a CAGR of 6.8% in the forecast period of 2024-2032 to reach a value of USD 24.41 billion by 2032.

 

Retinitis Pigmentosa Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The Asia Pacific Region to Witness the Fastest Growth in the Retinitis Pigmentosa Treatment Industry, Owing to a Large Patient Pool

The market for retinitis pigmentosa is supported by the large share of the market from the North America and Europe region collectively. This can be attributed to the upcoming approvals, and a surge in the number of research and awareness regarding the disorder, greater affordability, rise in product offerings, and an increase in demand for early treatment. The trend is expected to persist in the forecast period as well. The Asia Pacific region is expected to accelerate at a high rate over the forecast period. The region is governed by factors, such as the rise in the adoption of new products, large patient pool, and an increase in the demand for retinitis pigmentosa treatment in the emerging economies, like India and China. The market is also positively influenced by the inflating disposable incomes, changing lifestyles, and rapid urbanisation.

 

Retinitis Pigmentosa Treatment Market by End Use

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Retinitis Pigmentosa Treatment: Market Segmentation

Retinitis pigmentosa treatment refers to the treatment of retinitis pigmentosa, which is a group of rare genetic disorders, which entail the breakdown and loss of cells in the retina. Common symptoms of retinitis pigmentosa include problems in seeing at night and a loss of peripheral vision.

On the basis of type, the market is divided into:

  • Autosomal Recessive RP
  • Autosomal Dominant RP
  • X-Linked RP

Based on treatment, the industry can be segmented into:

  • Drug
  • Device
  • Surgery

Drug is divided on the basis of type into vitamin A palmitate and acetazolamide, among others. Device is further divided on the basis of type into sunglasses, implants, and others. Surgery is divided on the basis of type into retinal transplantation and corneal neurotization, among others.

On the basis of distribution channel, the industry is categorised into:

  • Hospital Retailer
  • Retail Retailer
  • Online

Based on end use, the industry is segmented into:

  • Hospitals
  • Special Clinics
  • Home Care
  • Ophthalmologist
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Retinitis Pigmentosa Treatment Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Rise in the Patients Suffering from Retinitis Pigmentosa to Aid the Retinitis Pigmentosa Treatment Industry Growth

The market for retinitis pigmentosa treatment is being driven by the rise in the patients suffering from retinitis pigmentosa across the globe. The market forces, such as rich product pipeline and increase in the funds for researchers developing new innovative drugs for the treatment of retinitis pigmentosa, are expected to aid the market growth of retinitis pigmentosa treatment over the forecast period. In addition, the rise in the special designation from the supervisory to offer a treatment to the patients as soon as possible is invigorating the market growth.

 

Key Industry Players in the Global Retinitis Pigmentosa Treatment Market

The report gives a detailed analysis of the following key players in the global retinitis pigmentosa treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Ionis Pharmaceuticals, Inc.
  • Orphagen Pharmaceuticals, Inc.
  • ReNeuron Group plc
  • Ocugen, Inc.
  • MeiraGTx Limited.
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Treatment
  • Distribution Channel
  • End Use
  • Region
Breakup by Type
  • Autosomal Recessive RP
  • Autosomal Dominant RP
  • X-Linked RP
Breakup by Treatment
  • Drug
  • Device
  • Surgery
Breakup by Distribution Channel
  • Hospital Retailer
  • Retail Retailer
  • Online
Breakup by End Use
  • Hospitals
  • Special Clinics
  • Home Care
  • Ophthalmologist
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Ionis Pharmaceuticals, Inc.
  • Orphagen Pharmaceuticals, Inc.
  • ReNeuron Group plc
  • Ocugen, Inc.
  • MeiraGTx Limited.
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Retinitis Pigmentosa Treatment Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Retinitis Pigmentosa Treatment Historical Market (2018-2023) 
    8.3    Global Retinitis Pigmentosa Treatment Market Forecast (2024-2032)
    8.4    Global Retinitis Pigmentosa Treatment Market by Type
        8.4.1    Autosomal Recessive RP
            8.4.1.1    Historical Trend (2018-2023)
            8.4.1.2    Forecast Trend (2024-2032)
        8.4.2    Autosomal Dominant RP
            8.4.2.1    Historical Trend (2018-2023)
            8.4.2.2    Forecast Trend (2024-2032)
        8.4.3    X-Linked RP
            8.4.3.1    Historical Trend (2018-2023)
            8.4.3.2    Forecast Trend (2024-2032)
    8.5    Global Retinitis Pigmentosa Treatment Market by Treatment 
        8.5.1    Drug
            8.5.1.1    Historical Trend (2018-2023)
            8.5.1.2    Forecast Trend (2024-2032)
            8.5.1.3    Breakup by Type
                8.5.1.3.1    Vitamin A Palmitate
                    8.5.1.3.1.1    Historical Trend (2018-2023)
                    8.5.1.3.1.2    Forecast Trend (2024-2032)
                8.5.1.3.2    Acetazolamide
                    8.5.1.3.2.1    Historical Trend (2018-2023)
                    8.5.1.3.2.2    Forecast Trend (2024-2032)
                8.5.1.3.3    Others
        8.5.2    Device
            8.5.2.1    Historical Trend (2018-2023)
            8.5.2.2    Forecast Trend (2024-2032)
            8.5.2.3    Breakup by Type
                8.5.2.3.1    Sunglasses
                    8.5.2.3.1.1    Historical Trend (2018-2023)
                    8.5.2.3.1.2    Forecast Trend (2024-2032)
                8.5.2.3.2    Implants
                    8.5.2.3.2.1    Historical Trend (2018-2023)
                    8.5.2.3.2.2    Forecast Trend (2024-2032)
                8.5.2.3.3    Others
        8.5.3    Surgery
            8.5.3.1    Historical Trend (2018-2023)
            8.5.3.2    Forecast Trend (2024-2032)
            8.5.3.3    Breakup by Type
                8.5.3.3.1    Retinal Transplantation
                    8.5.3.3.1.1    Historical Trend (2018-2023)
                    8.5.3.3.1.2    Forecast Trend (2024-2032)
                8.5.3.3.2    Corneal Neurotization
                    8.5.3.3.2.1    Historical Trend (2018-2023)
                    8.5.3.3.2.2    Forecast Trend (2024-2032)
                8.5.3.3.3    Others
    8.6    Global Retinitis Pigmentosa Treatment Market by Distribution Channel
        8.6.1    Hospital Retailer
            8.6.1.1    Historical Trend (2018-2023)
            8.6.1.2    Forecast Trend (2024-2032)
        8.6.2    Retail Retailer
            8.6.2.1    Historical Trend (2018-2023)
            8.6.2.2    Forecast Trend (2024-2032)
        8.6.3    Online
            8.6.3.1    Historical Trend (2018-2023)
            8.6.3.2    Forecast Trend (2024-2032)
    8.7    Global Retinitis Pigmentosa Treatment Market by End Use
        8.7.1    Hospitals
            8.7.1.1    Historical Trend (2018-2023)
            8.7.1.2    Forecast Trend (2024-2032)
        8.7.2    Special Clinics
            8.7.2.1    Historical Trend (2018-2023)
            8.7.2.2    Forecast Trend (2024-2032)
        8.7.3    Home Care
            8.7.3.1    Historical Trend (2018-2023)
            8.7.3.2    Forecast Trend (2024-2032)
        8.7.4    Ophthalmologist
            8.7.4.1    Historical Trend (2018-2023)
            8.7.4.2    Forecast Trend (2024-2032)
        8.7.5    Others 
    8.8    Global Retinitis Pigmentosa Treatment Market by Region
        8.8.1    North America
            8.8.1.1    Historical Trend (2018-2023)
            8.8.1.2    Forecast Trend (2024-2032)
        8.8.2    Europe
            8.8.2.1    Historical Trend (2018-2023)
            8.8.2.2    Forecast Trend (2024-2032)
        8.8.3    Asia Pacific
            8.8.3.1    Historical Trend (2018-2023)
            8.8.3.2    Forecast Trend (2024-2032)
        8.8.4    Latin America
            8.8.4.1    Historical Trend (2018-2023)
            8.8.4.2    Forecast Trend (2024-2032)
        8.8.5    Middle East and Africa
            8.8.5.1    Historical Trend (2018-2023)
            8.8.5.2    Forecast Trend (2024-2032)
9    North America Retinitis Pigmentosa Treatment Market Analysis
    9.1    United States of America
        9.1.1    Historical Trend (2018-2023)
        9.1.2    Forecast Trend (2024-2032)
    9.2    Canada
        9.2.1    Historical Trend (2018-2023)
        9.2.2    Forecast Trend (2024-2032)
10    Europe Retinitis Pigmentosa Treatment Market Analysis
    10.1    United Kingdom
        10.1.1    Historical Trend (2018-2023)
        10.1.2    Forecast Trend (2024-2032)
    10.2    Germany
        10.2.1    Historical Trend (2018-2023)
        10.2.2    Forecast Trend (2024-2032)
    10.3    France
        10.3.1    Historical Trend (2018-2023)
        10.3.2    Forecast Trend (2024-2032)
    10.4    Italy
        10.4.1    Historical Trend (2018-2023)
        10.4.2    Forecast Trend (2024-2032)
    10.5    Others
11    Asia Pacific Retinitis Pigmentosa Treatment Market Analysis
    11.1    China
        11.1.1    Historical Trend (2018-2023)
        11.1.2    Forecast Trend (2024-2032)
    11.2    Japan
        11.2.1    Historical Trend (2018-2023)
        11.2.2    Forecast Trend (2024-2032)
    11.3    India
        11.3.1    Historical Trend (2018-2023)
        11.3.2    Forecast Trend (2024-2032)
    11.4    ASEAN
        11.4.1    Historical Trend (2018-2023)
        11.4.2    Forecast Trend (2024-2032)
    11.5    Australia
        11.5.1    Historical Trend (2018-2023)
        11.5.2    Forecast Trend (2024-2032)
    11.6    Others
12    Latin America Retinitis Pigmentosa Treatment Market Analysis
    12.1    Brazil
        12.1.1    Historical Trend (2018-2023)
        12.1.2    Forecast Trend (2024-2032)
    12.2    Argentina
        12.2.1    Historical Trend (2018-2023)
        12.2.2    Forecast Trend (2024-2032)
    12.3    Mexico
        12.3.1    Historical Trend (2018-2023)
        12.3.2    Forecast Trend (2024-2032)
    12.4    Others
13    Middle East and Africa Retinitis Pigmentosa Treatment Market Analysis
    13.1    Saudi Arabia
        13.1.1    Historical Trend (2018-2023)
        13.1.2    Forecast Trend (2024-2032)
    13.2    United Arab Emirates
        13.2.1    Historical Trend (2018-2023)
        13.2.2    Forecast Trend (2024-2032)
    13.3    Nigeria
        13.3.1    Historical Trend (2018-2023)
        13.3.2    Forecast Trend (2024-2032)
    13.4    South Africa
        13.4.1    Historical Trend (2018-2023)
        13.4.2    Forecast Trend (2024-2032)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Value Chain Analysis
16    Competitive Landscape

    16.1    Market Structure
    16.2    Company Profiles
        16.2.1    Ionis Pharmaceuticals, Inc.
            16.2.1.1    Company Overview
            16.2.1.2    Product Portfolio
            16.2.1.3    Demographic Reach and Achievements
            16.2.1.4    Certifications
        16.2.2    Orphagen Pharmaceuticals, Inc.
            16.2.2.1    Company Overview
            16.2.2.2    Product Portfolio
            16.2.2.3    Demographic Reach and Achievements
            16.2.2.4    Certifications
        16.2.3    ReNeuron Group plc
            16.2.3.1    Company Overview
            16.2.3.2    Product Portfolio
            16.2.3.3    Demographic Reach and Achievements
            16.2.3.4    Certifications
        16.2.4    Ocugen, Inc.
            16.2.4.1    Company Overview
            16.2.4.2    Product Portfolio
            16.2.4.3    Demographic Reach and Achievements
            16.2.4.4    Certifications
        16.2.5    MeiraGTx Limited.
            16.2.5.1    Company Overview
            16.2.5.2    Product Portfolio
            16.2.5.3    Demographic Reach and Achievements
            16.2.5.4    Certifications
        16.2.6    Others
17    Key Trends and Developments in the Market


List of Key Figures and Tables

1.    Global Retinitis Pigmentosa Treatment Market: Key Industry Highlights, 2018 and 2032
2.    Global Retinitis Pigmentosa Treatment Historical Market: Breakup by Type (USD Billion), 2018-2023
3.    Global Retinitis Pigmentosa Treatment Market Forecast: Breakup by Type (USD Billion), 2024-2032
4.    Global Retinitis Pigmentosa Treatment Historical Market: Breakup by Treatment (USD Billion), 2018-2023
5.    Global Retinitis Pigmentosa Treatment Market Forecast: Breakup by Treatment (USD Billion), 2024-2032
6.    Global Retinitis Pigmentosa Treatment Historical Market: Breakup by Distribution Channel (USD Billion), 2018-2023
7.    Global Retinitis Pigmentosa Treatment Market Forecast: Breakup by Distribution Channel (USD Billion), 2024-2032
8.    Global Retinitis Pigmentosa Treatment Historical Market: Breakup by End Use (USD Billion), 2018-2023
9.    Global Retinitis Pigmentosa Treatment Market Forecast: Breakup by End Use (USD Billion), 2024-2032
10.    Global Retinitis Pigmentosa Treatment Historical Market: Breakup by Region (USD Billion), 2018-2023
11.    Global Retinitis Pigmentosa Treatment Market Forecast: Breakup by Region (USD Billion), 2024-2032
12.    North America Retinitis Pigmentosa Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
13.    North America Retinitis Pigmentosa Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
14.    Europe Retinitis Pigmentosa Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
15.    Europe Retinitis Pigmentosa Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
16.    Asia Pacific Retinitis Pigmentosa Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
17.    Asia Pacific Retinitis Pigmentosa Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
18.    Latin America Retinitis Pigmentosa Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
19.    Latin America Retinitis Pigmentosa Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
20.    Middle East and Africa Retinitis Pigmentosa Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
21.    Middle East and Africa Retinitis Pigmentosa Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
22.    Global Retinitis Pigmentosa Treatment Market Structure

Key Questions Answered in the Report

The global retinitis pigmentosa treatment market is being driven by the rising retinal disorder treatment market, which is projected to grow at a CAGR of 6.8% between 2024 and 2032.

The global retinal disorder treatment market is estimated to reach about USD 24.41 billion by 2032 and is expected to continue to support the growth of the retinitis pigmentosa treatment industry.

The major drivers of the industry, such as the surge in the number of research and awareness regarding the disorder, greater affordability, rise in product offerings, and an increase in demand for early treatment, are expected to aid the market growth.

The key trend guiding the growth of the market includes the increase in the funds for researchers developing new innovative drugs for the treatment of retinitis pigmentosa.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The significant types of retinitis pigmentosa treatment in the market are autosomal recessive RP, autosomal dominant RP, and X-linked RP.

The treatments of retinitis pigmentosa include drug, device, and surgery.

The major distribution channel in the industry are hospital retailer, retail retailer, and online.

The leading end use sectors in the market are hospitals, special clinics, home care, and ophthalmologist, among others.

The major players in the industry are Ionis Pharmaceuticals, Inc., Orphagen Pharmaceuticals, Inc., ReNeuron Group plc, Ocugen, Inc., and MeiraGTx Limited., among others.

Analyst Review

The global retinitis pigmentosa treatment market is being driven by the rising research in the industry and the growing retinal disorder treatment market. Aided by the rising investments into drug development, the retinal disorder treatment market is expected to witness a healthy growth in the forecast period of 2024-2032, growing at a CAGR of 6.8%. The retinal disorder treatment industry is projected to reach USD 24.41 billion by 2032.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on type, the market is segmented into autosomal recessive RP, autosomal dominant RP, and X-linked RP. On the basis of treatment, the industry is divided into drug, device, and surgery. By distribution channel, the industry is segmented into hospital retailer, retail retailer, and online. Based on end use, the market is divided into hospitals, special clinics, home care, and ophthalmologist, among others. The major regional markets for retinitis pigmentosa treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Ionis Pharmaceuticals, Inc., Orphagen Pharmaceuticals, Inc., ReNeuron Group plc, Ocugen, Inc., and MeiraGTx Limited., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER